Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02843620

Efficacy and Safety of b-2Cool on Adults With Joint Discomfort

Randomized Double-blind, Placebo Controlled Study to Asses the Efficacy and Safety of a Native Collagen Food Supplement on Joint Function, Ultrasound Evolution and Quality of Life of Adults With Moderate Knee Pain

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Bioiberica · Industry
Sex
All
Age
40 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This study evaluates the effects of 40 mg of b-2Cool, a food supplement rich in native type-II collagen, on healthy adults with joint discomfort. Half of the participants will receive the b-2Cool containing supplement while the other half will receive a placebo pill.

Detailed description

Previous studies had shown the efficacy of the intake of native collagen to relieve pain in healthy patients with joint discomfort. Native collagen is detected in the gut's Peyer's patches and, thanks to a mechanism known as oral tolerisation, reduces the autoimmune attack to joints' collagen improving joint function and pain. Oral tolerance consists of two phases of immune response: the maintenance of homeostasis and the suppression of immune responses mediated by Ag-specific regulatory T cells. T-cells detect the epitopes of type-II collagen in the gut and suppress the immune response against bodily type-II collagen. Then, these regulatory T cells generated in the gut are presumed to migrate to a local microenvironment where a protein analogous to the orally dosed antigen resides, in this case type-II collagen. Upon reactivation in a new microenvironment, regulatory cells will suppress ongoing inflammation.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTb-2Coolb-2Cool® is native type II collagen extracted from chicken sternums
OTHERPlaceboExcipients only

Timeline

Start date
2018-07-01
Primary completion
2018-07-01
Completion
2018-07-01
First posted
2016-07-26
Last updated
2018-07-20

Source: ClinicalTrials.gov record NCT02843620. Inclusion in this directory is not an endorsement.

Efficacy and Safety of b-2Cool on Adults With Joint Discomfort (NCT02843620) · Clinical Trials Directory